Table 3.
Models | IDI (95% CI) | P-value | Continuous NRI (95% CI) | P-value |
---|---|---|---|---|
2-year risk prediction | ||||
6-variable vs 8-variable | − 0.016 (− 0.025, − 0.008) | < 0.01 | − 0.331 (− 0.364, − 0.272) | < 0.01 |
4-variable vs 8-variable | − 0.016 (− 0.024, − 0.010) | < 0.01 | − 0.330 (− 0.365, − 0.299) | < 0.01 |
4-variable vs 6-variable | 0.000 (− 0.001, 0.002) | 0.81 | − 0.186 (− 0.281, 0.182) | 0.46 |
5-year risk prediction | ||||
6-variable vs 8-variable | − 0.012 (− 0.019, − 0.006) | < 0.01 | − 0.317 (− 0.375, − 0.262) | < 0.01 |
4-variable vs 8-variable | − 0.011 (− 0.017, − 0.006) | < 0.01 | − 0.322 (− 0.367, − 0.272) | < 0.01 |
4-variable vs 6-variable | 0.000 (− 0.001, 0.001) | 0.75 | 0.165 (− 0.067, 0.253) | 0.24 |
ESRD end-stage renal disease, CKD chronic kidney disease, IDI Integrated Discrimination Index, NRI net reclassification improvement.